OLD Mission Capital LLC Acquires Shares of 65,023 Smith & Nephew plc (NYSE:SNN)

OLD Mission Capital LLC bought a new position in shares of Smith & Nephew plc (NYSE:SNN) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 65,023 shares of the medical equipment provider’s stock, valued at approximately $1,598,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Principal Securities Inc. boosted its holdings in Smith & Nephew by 87.6% in the 4th quarter. Principal Securities Inc. now owns 1,480 shares of the medical equipment provider’s stock valued at $36,000 after purchasing an additional 691 shares during the last quarter. R Squared Ltd acquired a new position in Smith & Nephew in the fourth quarter valued at approximately $41,000. National Bank of Canada FI grew its position in Smith & Nephew by 36.5% in the fourth quarter. National Bank of Canada FI now owns 1,667 shares of the medical equipment provider’s stock worth $41,000 after acquiring an additional 446 shares during the period. Hara Capital LLC raised its position in Smith & Nephew by 391.4% in the fourth quarter. Hara Capital LLC now owns 2,457 shares of the medical equipment provider’s stock valued at $60,000 after purchasing an additional 1,957 shares during the period. Finally, GAMMA Investing LLC lifted its stake in shares of Smith & Nephew by 31.8% in the 4th quarter. GAMMA Investing LLC now owns 2,975 shares of the medical equipment provider’s stock valued at $73,000 after purchasing an additional 718 shares during the last quarter. Institutional investors and hedge funds own 25.64% of the company’s stock.

Smith & Nephew Stock Down 0.2 %

Shares of NYSE:SNN opened at $28.13 on Thursday. The firm’s 50-day moving average is $27.30 and its two-hundred day moving average is $26.89. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.51 and a quick ratio of 1.11. Smith & Nephew plc has a 1 year low of $23.65 and a 1 year high of $31.72. The firm has a market capitalization of $12.30 billion, a PE ratio of 13.02, a price-to-earnings-growth ratio of 1.26 and a beta of 0.83.

Smith & Nephew Increases Dividend

The firm also recently announced a semi-annual dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.447 per share. The ex-dividend date of this dividend is Friday, March 28th. This is a positive change from Smith & Nephew’s previous semi-annual dividend of $0.29. This represents a yield of 2.5%. Smith & Nephew’s dividend payout ratio is 41.20%.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. UBS Group lowered shares of Smith & Nephew from a “buy” rating to a “neutral” rating in a report on Wednesday, March 12th. StockNews.com upgraded shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a report on Wednesday, February 26th. Finally, Canaccord Genuity Group reissued a “hold” rating and issued a $27.00 target price on shares of Smith & Nephew in a research report on Monday, March 17th. Four research analysts have rated the stock with a hold rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $27.00.

About Smith & Nephew

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.